75
Views
52
CrossRef citations to date
0
Altmetric
Review

Therapeutic potential of retroviral RNAi vectors

&
Pages 319-327 | Published online: 03 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Xiawei Cheng, Xiaoxin Zhang, Yuqiang Zhou, Chunmei Zhang & Zi-Chun Hua. (2014) A Salmonella Typhimurium mutant strain capable of RNAi delivery. Cancer Biology & Therapy 15:8, pages 1068-1076.
Read now
TerryG. Wise, DarrenJ. Schafer, LukeS. Lambeth, ScottG. Tyack, MatthewP. Bruce, RobertJ. Moore & TimJ. Doran. (2007) Characterization and Comparison of Chicken U6 Promoters for the Expression of Short Hairpin RNAs. Animal Biotechnology 18:3, pages 153-162.
Read now
Damon Sutton, Saejeong Kim, Xintao Shuai, Konstantin Leskov, Joao T Marques, Bryan RG Williams, David A Boothman & Jinming Gao. (2006) Efficient suppression of secretory clusterin levels by polymer-siRNA nanocomplexes enhances ionizing radiation lethality in human MCF-7 breast cancer cells in vitro. International Journal of Nanomedicine 1:2, pages 155-162.
Read now
Charles N Landen, Michael S Kinch & Anil K Sood. (2005) EphA2 as a target for ovarian cancer therapy. Expert Opinion on Therapeutic Targets 9:6, pages 1179-1187.
Read now
Raymond M Schiffelers, Inge van Rooy & Gert Storm. (2005) siRNA-mediated inhibition of angiogenesis. Expert Opinion on Biological Therapy 5:3, pages 359-368.
Read now
Jae-Hyung Jang, Tiffany L Houchin & Lonnie D Shea. (2004) Gene delivery from polymer scaffolds for tissue engineering. Expert Review of Medical Devices 1:1, pages 127-138.
Read now

Articles from other publishers (46)

Kenneth Lundstrom. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity 763 776 .
Zaret G. Denieva, Uliana A. Budanova & Yurii L. Sebyakin. (2021) Irregular cationic lipotetrapeptides for pharmaceutical multifunctional transport systems. Mendeleev Communications 31:4, pages 509-511.
Crossref
Yang Liu & Leaf Huang. 2021. Design and Delivery of SiRNA Therapeutics. Design and Delivery of SiRNA Therapeutics 159 169 .
Kenneth Lundstrom. (2020) Viral Vectors Applied for RNAi-Based Antiviral Therapy. Viruses 12:9, pages 924.
Crossref
Michael J. Wagner, Rahul Mitra, Mark J. McArthur, Wallace Baze, Kirstin Barnhart, Sherry Y. Wu, Cristian Rodriguez-Aguayo, Xinna Zhang, Robert L. Coleman, Gabriel Lopez-Berestein & Anil K. Sood. (2017) Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA). Molecular Cancer Therapeutics 16:6, pages 1114-1123.
Crossref
Nishtha Panwar, Chengbin Yang, Feng Yin, Ho Sup Yoon, Tjin Swee Chuan & Ken-Tye Yong. (2015) RNAi-based therapeutic nanostrategy: IL-8 gene silencing in pancreatic cancer cells using gold nanorods delivery vehicles. Nanotechnology 26:36, pages 365101.
Crossref
Eun Jung Lee, So Jin Lee, Yoon-Sik Kang, Ju Hee Ryu, Koo Chul Kwon, Eunji Jo, Ji Young Yhee, Ick Chan Kwon, Kwangmeyung Kim & Jeewon Lee. (2015) Engineered Proteinticles for Targeted Delivery of siRNA to Cancer Cells. Advanced Functional Materials 25:8, pages 1279-1286.
Crossref
Mahtab Dastpak, Maryam M. Matin, Moein Farshchian, Yvan Arsenijevic, Madjid Momeni-Moghaddam, Sajjad Sisakhtnezhad, Sohrab Boozarpour, Hamid Reza Bidkhori, Mahdi Mirahmadi & Ahmad Reza Bahrami. (2014) Construction and Quantitative Evaluation of a Dual Specific Promoter System for Monitoring the Expression Status of Stra8 and c-kit Genes. Molecular Biotechnology 56:12, pages 1100-1109.
Crossref
Maneesh Gujrati, Anthony Malamas, Tesia Shin, Erlei Jin, Yunlu Sun & Zheng-Rong Lu. (2014) Multifunctional Cationic Lipid-Based Nanoparticles Facilitate Endosomal Escape and Reduction-Triggered Cytosolic siRNA Release. Molecular Pharmaceutics 11:8, pages 2734-2744.
Crossref
G. Salzano, R. Riehle, G. Navarro, F. Perche, G. De Rosa & V.P. Torchilin. (2014) Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: A promising strategy to overcome drug resistance in cancer. Cancer Letters 343:2, pages 224-231.
Crossref
Lee Adam Wheeler. (2014) Silencing Sexually Transmitted Infections: Topical siRNA-Based Interventions for the Prevention of HIV and HSV. Infectious Diseases in Obstetrics and Gynecology 2014, pages 1-11.
Crossref
Eveline Edith Salcher & Ernst Wagner. 2014. Nucleic Acid Nanotechnology. Nucleic Acid Nanotechnology 245 260 .
FEIFEI GUO, QINGYING XUN & HUAIJUN ZHOU. (2013) Treatment with Tie2-siRNA in combination with carboplatin suppresses the growth of Ishikawa human endometrial carcinoma cell xenografts in vivo. Oncology Letters 5:6, pages 1777-1782.
Crossref
Lina Cui, Jessica L. Cohen, Crystal K. Chu, Peter R. Wich, Paul H. Kierstead & Jean M. J. Fréchet. (2012) Conjugation Chemistry through Acetals toward a Dextran-Based Delivery System for Controlled Release of siRNA. Journal of the American Chemical Society 134:38, pages 15840-15848.
Crossref
Yan TAN & Xing-Mei ZHANG. (2012) Aptamer Mediated Delivery of Small Interfering RNAs*. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS 39:5, pages 410-415.
Crossref
Kyung-mi ChoiSeung-Hye ChoiHyesung JeonIn-San KimHyung Jun Ahn. (2011) Chimeric Capsid Protein as a Nanocarrier for siRNA Delivery: Stability and Cellular Uptake of Encapsulated siRNA. ACS Nano 5:11, pages 8690-8699.
Crossref
Ian Holt & Y. Chan N. Pham. 2011. Renewable Resources for Functional Polymers and Biomaterials. Renewable Resources for Functional Polymers and Biomaterials 399 429 .
Diana B. Burr, Samuel A. Molina, Debarshi Banerjee, Derek M. Low & Dolores J. Takemoto. (2011) Treatment with connexin 46 siRNA suppresses the growth of human Y79 retinoblastoma cell xenografts in vivo. Experimental Eye Research 92:4, pages 251-259.
Crossref
Gabriel J. Villares, Maya Zigler & Menashe Bar-Eli. (2011) The Emerging Role of the Thrombin Receptor (PAR-1) in Melanoma Metastasis - a Possible Therapeutic Target. Oncotarget 2:1-2, pages 8-17.
Crossref
Ralph A. Tripp & Stephen Mark Tompkins. 2011. RNA Interference. RNA Interference 272 305 .
Min Suk Shim & Young Jik Kwon. (2010) Efficient and targeted delivery of siRNA in vivo . The FEBS Journal 277:23, pages 4814-4827.
Crossref
Andrew V. Oleinikov & Matthew D. Gray. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia 1 40 .
Weiwei Gao, Zeyu Xiao, Alex Radovic-Moreno, Jinjun Shi, Robert Langer & Omid C. Farokhzad. 2010. RNA Therapeutics. RNA Therapeutics 53 67 .
J.C. Gallardo-Pérez, M. Espinosa, G. Ceballos-Cancino, A. Daniel, S. Rodríguez-Enríquez, A. Aviles, R. Moreno-Sánchez, J. Melendez-Zajgla & V. Maldonado. (2009) NF-kappa B is required for the development of tumor spheroids. Journal of Cellular Biochemistry 108:1, pages 169-180.
Crossref
Hui YANG, Dong HUANG, Shai-hong ZHU, Xue-bin YAN, Yong-hong GU, Hui YAN & Li-xiang WU. (2008) Preparation and application of hydroxyapatite(HA) nanoparticles/NR2B-siRNA complex. Transactions of Nonferrous Metals Society of China 18:4, pages 913-918.
Crossref
Zsuzsanna Rácz & Péter Hamar. (2008) SiRNA technology, the gene therapy of the future?. Orvosi Hetilap 149:4, pages 153-159.
Crossref
Alakananda Basu, Shalini D. Persaud & Usha Sivaprasad. 2008. Programmed Cell Death, The Biology and Therapeutic Implications of Cell Death, Part B. Programmed Cell Death, The Biology and Therapeutic Implications of Cell Death, Part B 141 157 .
Michael Famulok, Jörg S. Hartig & Günter Mayer. (2007) Functional Aptamers and Aptazymes in Biotechnology, Diagnostics, and Therapy. Chemical Reviews 107:9, pages 3715-3743.
Crossref
S Sabbioni, E Callegari, M Manservigi, R Argnani, A Corallini, M Negrini & R Manservigi. (2006) Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA. Gene Therapy 14:5, pages 459-464.
Crossref
N Nakai, T Kishida, M Shin-Ya, J Imanishi, Y Ueda, S Kishimoto & O Mazda. (2006) Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf. Gene Therapy 14:4, pages 357-365.
Crossref
Jyotsnabaran Halder, Aparna A. Kamat, Charles N. LandenJr.Jr., Liz Y. Han, Susan K. Lutgendorf, Yvonne G. Lin, William M. Merritt, Nicholas B. Jennings, Arturo Chavez-Reyes, Robert L. Coleman, David M. Gershenson, Rosemarie Schmandt, Steven W. Cole, Gabriel Lopez-Berestein & Anil K. Sood. (2006) Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy . Clinical Cancer Research 12:16, pages 4916-4924.
Crossref
James O McNamara, Eran R Andrechek, Yong Wang, Kristi D Viles, Rachel E Rempel, Eli Gilboa, Bruce A Sullenger & Paloma H Giangrande. (2006) Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras. Nature Biotechnology 24:8, pages 1005-1015.
Crossref
Juan Huang, Ping Jiang, Yufeng Li, Jiarong Xu, Wenming Jiang & Xianwei Wang. (2006) Inhibition of porcine reproductive and respiratory syndrome virus replication by short hairpin RNA in MARC-145 cells. Veterinary Microbiology 115:4, pages 302-310.
Crossref
Gregory Cesarone, Cecilia Garofalo, Marc T. Abrams, Olga Igoucheva, Vitali Alexeev, Kyonggeun Yoon, Eva Surmacz & Eric Wickstrom. (2006) RNAi‐mediated silencing of insulin receptor substrate 1 (IRS‐1) enhances tamoxifen‐induced cell death in MCF‐7 breast cancer cells. Journal of Cellular Biochemistry 98:2, pages 440-450.
Crossref
Yi‐Yan Yang, Yong Wang, Ross Powell & Peggy Chan. (2006) POLYMERIC CORE‐SHELL NANOPARTICLES FOR THERAPEUTICS. Clinical and Experimental Pharmacology and Physiology 33:5-6, pages 557-562.
Crossref
S Guo, F Huang & P Guo. (2006) Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells. Gene Therapy 13:10, pages 814-820.
Crossref
Shirin Munir, Kuljeet Kaur & Vivek Kapur. (2006) Avian metapneumovirus phosphoprotein targeted RNA interference silences the expression of viral proteins and inhibits virus replication. Antiviral Research 69:1, pages 46-51.
Crossref
Charles N. LandenJr.Jr., Arturo Chavez-Reyes, Corazon Bucana, Rosemarie Schmandt, Michael T. Deavers, Gabriel Lopez-Berestein & Anil K. Sood. (2005) Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery . Cancer Research 65:15, pages 6910-6918.
Crossref
Teresa de los Santos, Qiaohua Wu, Sonia de Avila Botton & Marvin J. Grubman. (2005) Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus. Virology 335:2, pages 222-231.
Crossref
Qing Shao, Hongling Wang, Elizabeth McLachlan, Gregory I.L. Veitch & Dale W. Laird. (2005) Down-regulation of Cx43 by Retroviral Delivery of Small Interfering RNA Promotes an Aggressive Breast Cancer Cell Phenotype. Cancer Research 65:7, pages 2705-2711.
Crossref
Amine Bahi, Frederic Boyer, Manoj Kolira & Jean-Luc Dreyer. (2005) In vivo gene silencing of CD81 by lentiviral expression of small interference RNAs suppresses cocaine-induced behaviour. Journal of Neurochemistry 92:5, pages 1243-1255.
Crossref
P. Young. 2005. Hereditary Peripheral Neuropathies. Hereditary Peripheral Neuropathies 199 205 .
Ciriaco A. Piccirillo, Argyrios N. Theofilopoulos & Gérald J. Prud’homme. 2005. Gene Therapy of Autoimmune Diseases. Gene Therapy of Autoimmune Diseases 43 70 .
Rajnish S. Dave & Roger J. Pomerantz. (2004) Antiviral Effects of Human Immunodeficiency Virus Type 1-Specific Small Interfering RNAs against Targets Conserved in Select Neurotropic Viral Strains. Journal of Virology 78:24, pages 13687-13696.
Crossref
Jack R. Bennink & Tara N. Palmore. (2004) The promise of siRNAs for the treatment of influenza. Trends in Molecular Medicine 10:12, pages 571-574.
Crossref
Wen-Wen Lu, Yueh-Ying Hsu, Jyh-Yuan Yang & Szu-Hao Kung. (2004) Selective inhibition of enterovirus 71 replication by short hairpin RNAs. Biochemical and Biophysical Research Communications 325:2, pages 494-499.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.